Product Information
ACETAMINOPHEN 325 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0250 per EA under NDC 49483034010. Its NADAC has been published 401 times since Oct 24, 2018.
Strength
325 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483034010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
12/15/2011
Price Statistics
The NADAC for ACETAMINOPHEN 325 MG TABLET has been published 401 times since Oct 24, 2018, and over the history we have for it it has risen 47.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0250 per EA |
|---|---|
| All-time high | $0.0267 (Nov 13, 2024) |
| All-time low | $0.0135 (Dec 19, 2018) |
| 52-week high | $0.0267 |
| 52-week low | $0.0247 |
| Median price | $0.0232 |
| Average price | $0.0220 |
| Largest weekly change | +55.0% (Jan 20, 2021) |
| Weeks tracked | 401 |
| Tracking since | Oct 24, 2018 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0250 per EA (NDC 49483034010), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG TABLET has risen 47.3%. It has been tracked across 401 weekly CMS publications since Oct 24, 2018.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG TABLET?
Since Oct 24, 2018, the NADAC for ACETAMINOPHEN 325 MG TABLET has ranged from a low of $0.0135 (Dec 19, 2018) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0232 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 325 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ACETAMINOPHEN 325 MG TABLET, is $0.0110 per EA — about 56% below ACETAMINOPHEN 325 MG TABLET.
Who manufactures ACETAMINOPHEN 325 MG TABLET?
ACETAMINOPHEN 325 MG TABLET (NDC 49483034010) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification